论文部分内容阅读
选取2013年3月~2014年3月我院消化内科收治的105例HP感染患者,分为对照组55例和试验组50例。对照组患者予传统奥美拉唑+阿莫西林+克拉霉素治疗,试验组患者予雷贝拉唑+阿莫西林+左氧氟沙星治疗,观察、比较两组患者的治疗效果。结果试验组的HP根除率(96.00%)优于对照组(72.73%),试验组的不良反应发生率(2.00%)低于对照组(21.84%),两组间根除率及不良反应发生率比较,具有统计学意义(P<0.05)。左氧氟沙星联合雷贝拉唑和阿莫西林根除HP的临床疗效好,HP根除率高,不良反应少,可考虑于临床治疗中合理推广与应用。
105 cases of HP infection admitted to our hospital from March 2013 to March 2014 were divided into control group (55 cases) and experimental group (50 cases). Patients in the control group were treated with traditional omeprazole + amoxicillin + clarithromycin. Patients in the test group were treated with rabeprazole + amoxicillin + levofloxacin. The therapeutic effects were compared between the two groups. Results The eradication rate (96.00%) of the experimental group was better than that of the control group (72.73%). The incidence of adverse reactions in the experimental group (2.00%) was lower than that of the control group (21.84%). The eradication rate and incidence of adverse reactions Compared with statistical significance (P <0.05). Levofloxacin combined with rabeprazole and amoxicillin to eradicate HP clinical efficacy, HP eradication rate, adverse reactions, can be considered in the clinical treatment of reasonable promotion and application.